

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 4.29493915 |
| 2 | NIK/NF-kappaB signaling (GO:0038061) | 4.14655612 |
| 3 | protein localization to endosome (GO:0036010) | 3.73061603 |
| 4 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.71646108 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 3.58736792 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 3.58736792 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.58736792 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.58736792 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.58736792 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 3.58736792 |
| 11 | response to peptidoglycan (GO:0032494) | 3.52149545 |
| 12 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 3.46976993 |
| 13 | modulation by symbiont of host cellular process (GO:0044068) | 3.40039140 |
| 14 | COPI coating of Golgi vesicle (GO:0048205) | 3.38298912 |
| 15 | Golgi transport vesicle coating (GO:0048200) | 3.38298912 |
| 16 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.35262164 |
| 17 | myeloid dendritic cell differentiation (GO:0043011) | 3.30622454 |
| 18 | regulation of early endosome to late endosome transport (GO:2000641) | 3.27938428 |
| 19 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.21030405 |
| 20 | pentose-phosphate shunt (GO:0006098) | 3.18862792 |
| 21 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.11571644 |
| 22 | negative regulation of cell killing (GO:0031342) | 3.11571644 |
| 23 | modulation by virus of host process (GO:0019054) | 3.07438924 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.07331129 |
| 25 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.03266021 |
| 26 | regulation of defense response to virus by virus (GO:0050690) | 3.00527112 |
| 27 | barbed-end actin filament capping (GO:0051016) | 2.97943630 |
| 28 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.97548962 |
| 29 | leukocyte aggregation (GO:0070486) | 2.96178095 |
| 30 | detection of bacterium (GO:0016045) | 2.86752232 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.82237593 |
| 32 | detection of other organism (GO:0098543) | 2.78319801 |
| 33 | mannose metabolic process (GO:0006013) | 2.77804970 |
| 34 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.77489826 |
| 35 | regulation of mammary gland epithelial cell proliferation (GO:0033599) | 2.74977054 |
| 36 | 3-UTR-mediated mRNA stabilization (GO:0070935) | 2.74440236 |
| 37 | macrophage activation involved in immune response (GO:0002281) | 2.73659825 |
| 38 | positive regulation of protein dephosphorylation (GO:0035307) | 2.73030321 |
| 39 | immunoglobulin mediated immune response (GO:0016064) | 2.71664441 |
| 40 | response to muramyl dipeptide (GO:0032495) | 2.71293415 |
| 41 | myeloid dendritic cell activation (GO:0001773) | 2.70859060 |
| 42 | germinal center formation (GO:0002467) | 2.70786646 |
| 43 | pinocytosis (GO:0006907) | 2.70478776 |
| 44 | stress fiber assembly (GO:0043149) | 2.69791629 |
| 45 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.68687448 |
| 46 | proline biosynthetic process (GO:0006561) | 2.65956188 |
| 47 | cellular response to type I interferon (GO:0071357) | 2.65353748 |
| 48 | type I interferon signaling pathway (GO:0060337) | 2.65353748 |
| 49 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.65145388 |
| 50 | NADPH regeneration (GO:0006740) | 2.64133622 |
| 51 | regulation of extracellular matrix disassembly (GO:0010715) | 2.63395967 |
| 52 | ribosomal small subunit biogenesis (GO:0042274) | 2.63226578 |
| 53 | response to type I interferon (GO:0034340) | 2.62242595 |
| 54 | protein retention in ER lumen (GO:0006621) | 2.62192336 |
| 55 | amyloid precursor protein catabolic process (GO:0042987) | 2.61088280 |
| 56 | neutrophil activation involved in immune response (GO:0002283) | 2.60649976 |
| 57 | positive regulation of gamma-delta T cell activation (GO:0046645) | 2.60176572 |
| 58 | glucose catabolic process (GO:0006007) | 2.59505875 |
| 59 | negative regulation of interleukin-12 production (GO:0032695) | 2.59434413 |
| 60 | regulation of leukocyte degranulation (GO:0043300) | 2.56227603 |
| 61 | apoptotic process involved in morphogenesis (GO:0060561) | 2.54529582 |
| 62 | response to laminar fluid shear stress (GO:0034616) | 2.51837722 |
| 63 | maternal placenta development (GO:0001893) | 2.51725132 |
| 64 | adenosine receptor signaling pathway (GO:0001973) | 2.51550598 |
| 65 | response to host (GO:0075136) | 2.51376497 |
| 66 | response to host defenses (GO:0052200) | 2.51376497 |
| 67 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.51376497 |
| 68 | virion assembly (GO:0019068) | 2.50820632 |
| 69 | positive regulation of extracellular matrix organization (GO:1903055) | 2.47212108 |
| 70 | activation of MAPKKK activity (GO:0000185) | 2.46703349 |
| 71 | positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling | 2.45735415 |
| 72 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.45530275 |
| 73 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.45405608 |
| 74 | regulation of superoxide anion generation (GO:0032928) | 2.44198867 |
| 75 | glucose 6-phosphate metabolic process (GO:0051156) | 2.42986671 |
| 76 | tolerance induction (GO:0002507) | 2.40998237 |
| 77 | cellular response to virus (GO:0098586) | 2.40367494 |
| 78 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.40296681 |
| 79 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.40050585 |
| 80 | activation of Rac GTPase activity (GO:0032863) | 2.39870347 |
| 81 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.39052890 |
| 82 | GDP-mannose metabolic process (GO:0019673) | 2.39051434 |
| 83 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.38752995 |
| 84 | response to host immune response (GO:0052572) | 2.38752995 |
| 85 | negative regulation of cell size (GO:0045792) | 2.36545895 |
| 86 | T-helper 1 type immune response (GO:0042088) | 2.35024012 |
| 87 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.33841274 |
| 88 | viral protein processing (GO:0019082) | 2.33511634 |
| 89 | positive regulation of type 2 immune response (GO:0002830) | 2.29957070 |
| 90 | regulation of mast cell degranulation (GO:0043304) | 2.29579837 |
| 91 | regulation of podosome assembly (GO:0071801) | 2.29106537 |
| 92 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.27475430 |
| 93 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.25296356 |
| 94 | positive regulation of keratinocyte differentiation (GO:0045618) | 2.24648821 |
| 95 | glycosphingolipid catabolic process (GO:0046479) | 2.24625886 |
| 96 | focal adhesion assembly (GO:0048041) | 2.23783255 |
| 97 | cell-substrate adherens junction assembly (GO:0007045) | 2.23783255 |
| 98 | interferon-gamma-mediated signaling pathway (GO:0060333) | 2.23465870 |
| 99 | regulation of viral release from host cell (GO:1902186) | 2.23425451 |
| 100 | G-protein coupled purinergic receptor signaling pathway (GO:0035588) | 2.22845327 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.87276809 |
| 2 | MYC_22102868_ChIP-Seq_BL_Human | 2.65083743 |
| 3 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.61039236 |
| 4 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.60770596 |
| 5 | LXR_22292898_ChIP-Seq_THP-1_Human | 2.58508921 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.51182291 |
| 7 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.37538768 |
| 8 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.36463605 |
| 9 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.21736590 |
| 10 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.17816045 |
| 11 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.17558639 |
| 12 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.17483487 |
| 13 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.13279604 |
| 14 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 2.10977223 |
| 15 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 2.08379810 |
| 16 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.97139123 |
| 17 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.90275570 |
| 18 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.89204093 |
| 19 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.87051597 |
| 20 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.83038718 |
| 21 | MAF_26560356_Chip-Seq_TH1_Human | 1.69727416 |
| 22 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.69379863 |
| 23 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.63942251 |
| 24 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.57503134 |
| 25 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.56204612 |
| 26 | MAF_26560356_Chip-Seq_TH2_Human | 1.55408996 |
| 27 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.54625128 |
| 28 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.48948177 |
| 29 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.48224613 |
| 30 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.47287130 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.44864981 |
| 32 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.44303967 |
| 33 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.43662056 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.43661460 |
| 35 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.43483100 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.41085403 |
| 37 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.41077691 |
| 38 | UTX_26944678_Chip-Seq_JUKART_Human | 1.39196904 |
| 39 | P68_20966046_ChIP-Seq_HELA_Human | 1.39136154 |
| 40 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.38201895 |
| 41 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.37841021 |
| 42 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.37530093 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.37308693 |
| 44 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.35343407 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.31495146 |
| 46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.30563366 |
| 47 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.30284400 |
| 48 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.29865086 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.29623611 |
| 50 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.29542501 |
| 51 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.27600588 |
| 52 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.25802817 |
| 53 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.25642679 |
| 54 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25353456 |
| 55 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.24131266 |
| 56 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.24100078 |
| 57 | SMC4_20622854_ChIP-Seq_HELA_Human | 1.23533017 |
| 58 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.23212650 |
| 59 | ATF3_27146783_Chip-Seq_COLON_Human | 1.21515919 |
| 60 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.20937484 |
| 61 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.20730443 |
| 62 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.20576516 |
| 63 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.20170339 |
| 64 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19852644 |
| 65 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.19693681 |
| 66 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.19262367 |
| 67 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.18484565 |
| 68 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.18402294 |
| 69 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.17082235 |
| 70 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.17016399 |
| 71 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.16846877 |
| 72 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.16516502 |
| 73 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.16474995 |
| 74 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.14830520 |
| 75 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.14370063 |
| 76 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.12652398 |
| 77 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.12451962 |
| 78 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.12192836 |
| 79 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.11269835 |
| 80 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.10672177 |
| 81 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.10157326 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.09654749 |
| 83 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.09468114 |
| 84 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.09466125 |
| 85 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09272561 |
| 86 | SPI1_23127762_ChIP-Seq_K562_Human | 1.09157343 |
| 87 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 1.08252869 |
| 88 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.08221903 |
| 89 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.08171259 |
| 90 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.07493857 |
| 91 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.06896366 |
| 92 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.06524853 |
| 93 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.05691103 |
| 94 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.05522674 |
| 95 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.05190346 |
| 96 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.04572228 |
| 97 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.04365352 |
| 98 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.03891212 |
| 99 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.03639185 |
| 100 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.03198846 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005058_abnormal_lysosome_morphology | 3.72483782 |
| 2 | MP0003303_peritoneal_inflammation | 3.66915807 |
| 3 | MP0005451_abnormal_body_composition | 3.41986584 |
| 4 | MP0003436_decreased_susceptibility_to | 3.27704027 |
| 5 | MP0003705_abnormal_hypodermis_morpholog | 3.10945069 |
| 6 | MP0008260_abnormal_autophagy | 2.79913643 |
| 7 | MP0003300_gastrointestinal_ulcer | 2.71026014 |
| 8 | MP0009840_abnormal_foam_cell | 2.61802767 |
| 9 | MP0004510_myositis | 2.51558963 |
| 10 | MP0003191_abnormal_cellular_cholesterol | 2.47372349 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.07516026 |
| 12 | MP0000685_abnormal_immune_system | 2.03268906 |
| 13 | MP0003172_abnormal_lysosome_physiology | 2.00416904 |
| 14 | MP0001835_abnormal_antigen_presentation | 1.97587281 |
| 15 | MP0001790_abnormal_immune_system | 1.95852972 |
| 16 | MP0005387_immune_system_phenotype | 1.95852972 |
| 17 | MP0003453_abnormal_keratinocyte_physiol | 1.95104625 |
| 18 | MP0001873_stomach_inflammation | 1.92035336 |
| 19 | MP0002148_abnormal_hypersensitivity_rea | 1.91420490 |
| 20 | MP0005025_abnormal_response_to | 1.89882800 |
| 21 | MP0002419_abnormal_innate_immunity | 1.87499411 |
| 22 | MP0004947_skin_inflammation | 1.81356269 |
| 23 | MP0000858_altered_metastatic_potential | 1.80075768 |
| 24 | MP0009333_abnormal_splenocyte_physiolog | 1.79181365 |
| 25 | MP0009278_abnormal_bone_marrow | 1.75440258 |
| 26 | MP0009785_altered_susceptibility_to | 1.70811636 |
| 27 | MP0003763_abnormal_thymus_physiology | 1.70771353 |
| 28 | MP0010155_abnormal_intestine_physiology | 1.68610092 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.65440176 |
| 30 | MP0004858_abnormal_nervous_system | 1.63620101 |
| 31 | MP0005076_abnormal_cell_differentiation | 1.60652364 |
| 32 | MP0003075_altered_response_to | 1.59354647 |
| 33 | MP0002723_abnormal_immune_serum | 1.57417028 |
| 34 | MP0001849_ear_inflammation | 1.56764783 |
| 35 | MP0001800_abnormal_humoral_immune | 1.52009851 |
| 36 | MP0002452_abnormal_antigen_presenting | 1.51856008 |
| 37 | MP0006082_CNS_inflammation | 1.50157270 |
| 38 | MP0005464_abnormal_platelet_physiology | 1.50092197 |
| 39 | MP0003183_abnormal_peptide_metabolism | 1.48910999 |
| 40 | MP0003566_abnormal_cell_adhesion | 1.47824383 |
| 41 | MP0002420_abnormal_adaptive_immunity | 1.47652354 |
| 42 | MP0003724_increased_susceptibility_to | 1.47257360 |
| 43 | MP0002877_abnormal_melanocyte_morpholog | 1.47246903 |
| 44 | MP0001819_abnormal_immune_cell | 1.46994968 |
| 45 | MP0004185_abnormal_adipocyte_glucose | 1.46827905 |
| 46 | MP0002796_impaired_skin_barrier | 1.38996286 |
| 47 | MP0000490_abnormal_crypts_of | 1.35968430 |
| 48 | MP0000343_altered_response_to | 1.35892595 |
| 49 | MP0010234_abnormal_vibrissa_follicle | 1.34880055 |
| 50 | MP0005671_abnormal_response_to | 1.34327865 |
| 51 | MP0003329_amyloid_beta_deposits | 1.31677913 |
| 52 | MP0002998_abnormal_bone_remodeling | 1.31200525 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.31029011 |
| 54 | MP0001845_abnormal_inflammatory_respons | 1.30064010 |
| 55 | MP0000604_amyloidosis | 1.24320366 |
| 56 | MP0008438_abnormal_cutaneous_collagen | 1.23580866 |
| 57 | MP0002405_respiratory_system_inflammati | 1.23256205 |
| 58 | MP0004264_abnormal_extraembryonic_tissu | 1.23052580 |
| 59 | MP0002132_abnormal_respiratory_system | 1.21535600 |
| 60 | MP0002398_abnormal_bone_marrow | 1.19700550 |
| 61 | MP0000716_abnormal_immune_system | 1.15027075 |
| 62 | MP0005501_abnormal_skin_physiology | 1.10901278 |
| 63 | MP0008469_abnormal_protein_level | 1.10563996 |
| 64 | MP0003866_abnormal_defecation | 1.05454182 |
| 65 | MP0005023_abnormal_wound_healing | 1.05367852 |
| 66 | MP0002429_abnormal_blood_cell | 1.05281852 |
| 67 | MP0003091_abnormal_cell_migration | 1.04427335 |
| 68 | MP0004381_abnormal_hair_follicle | 1.03216096 |
| 69 | MP0003448_altered_tumor_morphology | 0.99823294 |
| 70 | MP0005390_skeleton_phenotype | 0.99430842 |
| 71 | MP0005310_abnormal_salivary_gland | 0.98271615 |
| 72 | MP0004233_abnormal_muscle_weight | 0.96347606 |
| 73 | MP0005666_abnormal_adipose_tissue | 0.95900369 |
| 74 | MP0002722_abnormal_immune_system | 0.95881983 |
| 75 | MP0005166_decreased_susceptibility_to | 0.95319380 |
| 76 | MP0002089_abnormal_postnatal_growth/wei | 0.94229140 |
| 77 | MP0000678_abnormal_parathyroid_gland | 0.93418058 |
| 78 | MP0003279_aneurysm | 0.91318021 |
| 79 | MP0005257_abnormal_intraocular_pressure | 0.91024061 |
| 80 | MP0001348_abnormal_lacrimal_gland | 0.89263229 |
| 81 | MP0000750_abnormal_muscle_regeneration | 0.89165438 |
| 82 | MP0000703_abnormal_thymus_morphology | 0.89089584 |
| 83 | MP0002139_abnormal_hepatobiliary_system | 0.86184878 |
| 84 | MP0000689_abnormal_spleen_morphology | 0.84908051 |
| 85 | MP0005375_adipose_tissue_phenotype | 0.82975506 |
| 86 | MP0001663_abnormal_digestive_system | 0.82607636 |
| 87 | MP0003656_abnormal_erythrocyte_physiolo | 0.81434170 |
| 88 | MP0003795_abnormal_bone_structure | 0.81102891 |
| 89 | MP0008874_decreased_physiological_sensi | 0.79820897 |
| 90 | MP0001853_heart_inflammation | 0.79707498 |
| 91 | MP0001216_abnormal_epidermal_layer | 0.79695889 |
| 92 | MP0002254_reproductive_system_inflammat | 0.79387984 |
| 93 | MP0001851_eye_inflammation | 0.78925492 |
| 94 | MP0002933_joint_inflammation | 0.77067162 |
| 95 | MP0004808_abnormal_hematopoietic_stem | 0.75597796 |
| 96 | MP0009931_abnormal_skin_appearance | 0.74849693 |
| 97 | MP0002277_abnormal_respiratory_mucosa | 0.73249863 |
| 98 | MP0002396_abnormal_hematopoietic_system | 0.72265613 |
| 99 | MP0002060_abnormal_skin_morphology | 0.68032809 |
| 100 | MP0005621_abnormal_cell_physiology | 0.67747598 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.72874163 |
| 2 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.72874163 |
| 3 | Abnormality of glycolipid metabolism (HP:0010969) | 3.72874163 |
| 4 | Eczematoid dermatitis (HP:0000976) | 3.58172591 |
| 5 | Vertebral compression fractures (HP:0002953) | 3.48875870 |
| 6 | Abnormality of macrophages (HP:0004311) | 3.32756451 |
| 7 | Distal lower limb muscle weakness (HP:0009053) | 3.09578242 |
| 8 | Dysostosis multiplex (HP:0000943) | 2.97837867 |
| 9 | Loss of speech (HP:0002371) | 2.90793046 |
| 10 | Axonal loss (HP:0003447) | 2.87253523 |
| 11 | Recurrent abscess formation (HP:0002722) | 2.66431089 |
| 12 | Increased cerebral lipofuscin (HP:0011813) | 2.58448825 |
| 13 | Recurrent bacterial skin infections (HP:0005406) | 2.55871062 |
| 14 | Protrusio acetabuli (HP:0003179) | 2.54914986 |
| 15 | Cholecystitis (HP:0001082) | 2.45337474 |
| 16 | Abnormal gallbladder physiology (HP:0012438) | 2.45337474 |
| 17 | Thin bony cortex (HP:0002753) | 2.43764600 |
| 18 | Cellulitis (HP:0100658) | 2.41091078 |
| 19 | Gastrointestinal stroma tumor (HP:0100723) | 2.39057170 |
| 20 | Hyperparathyroidism (HP:0000843) | 2.39031701 |
| 21 | Mediastinal lymphadenopathy (HP:0100721) | 2.34627354 |
| 22 | Ragged-red muscle fibers (HP:0003200) | 2.33014601 |
| 23 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31111612 |
| 24 | Obstructive lung disease (HP:0006536) | 2.31111612 |
| 25 | Purpura (HP:0000979) | 2.29322135 |
| 26 | Achilles tendon contracture (HP:0001771) | 2.28652421 |
| 27 | Hyperacusis (HP:0010780) | 2.27930706 |
| 28 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.27637391 |
| 29 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.27637391 |
| 30 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.27637391 |
| 31 | Increased serum ferritin (HP:0003281) | 2.21366123 |
| 32 | Neuronal loss in central nervous system (HP:0002529) | 2.19645686 |
| 33 | Gastrointestinal infarctions (HP:0005244) | 2.18046637 |
| 34 | Flat acetabular roof (HP:0003180) | 2.17862554 |
| 35 | J-shaped sella turcica (HP:0002680) | 2.15413739 |
| 36 | Premature rupture of membranes (HP:0001788) | 2.14445588 |
| 37 | Mucopolysacchariduria (HP:0008155) | 2.14087563 |
| 38 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.14087563 |
| 39 | Polygenic inheritance (HP:0010982) | 2.12998322 |
| 40 | Myositis (HP:0100614) | 2.12390348 |
| 41 | Increased IgE level (HP:0003212) | 2.12259322 |
| 42 | Petechiae (HP:0000967) | 2.11214356 |
| 43 | Abnormality of the Achilles tendon (HP:0005109) | 2.10733311 |
| 44 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.09982354 |
| 45 | Upper limb amyotrophy (HP:0009129) | 2.08104679 |
| 46 | Distal upper limb amyotrophy (HP:0007149) | 2.08104679 |
| 47 | Increased connective tissue (HP:0009025) | 2.05100173 |
| 48 | Nuclear cataract (HP:0100018) | 2.04743462 |
| 49 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.01862469 |
| 50 | Distal lower limb amyotrophy (HP:0008944) | 2.01856557 |
| 51 | Deep venous thrombosis (HP:0002625) | 2.00393211 |
| 52 | Abnormality of the thoracic spine (HP:0100711) | 1.99795735 |
| 53 | Long palpebral fissure (HP:0000637) | 1.97771599 |
| 54 | Bone pain (HP:0002653) | 1.97199158 |
| 55 | Interstitial pulmonary disease (HP:0006530) | 1.96343937 |
| 56 | Obstructive sleep apnea (HP:0002870) | 1.95164856 |
| 57 | Hypertensive crisis (HP:0100735) | 1.95149469 |
| 58 | Supranuclear gaze palsy (HP:0000605) | 1.95146376 |
| 59 | Segmental peripheral demyelination/remyelination (HP:0003481) | 1.94948509 |
| 60 | Cervical subluxation (HP:0003308) | 1.94047037 |
| 61 | Orchitis (HP:0100796) | 1.93020090 |
| 62 | Urticaria (HP:0001025) | 1.92316386 |
| 63 | Thoracic kyphosis (HP:0002942) | 1.90389018 |
| 64 | Emphysema (HP:0002097) | 1.89038518 |
| 65 | Meningitis (HP:0001287) | 1.88255319 |
| 66 | Metaphyseal cupping (HP:0003021) | 1.86540664 |
| 67 | Prolonged neonatal jaundice (HP:0006579) | 1.85354835 |
| 68 | Progressive neurologic deterioration (HP:0002344) | 1.83573240 |
| 69 | Progressive muscle weakness (HP:0003323) | 1.83269797 |
| 70 | Broad face (HP:0000283) | 1.83190309 |
| 71 | Hepatosplenomegaly (HP:0001433) | 1.83034671 |
| 72 | Cerebral inclusion bodies (HP:0100314) | 1.81881699 |
| 73 | Gastrointestinal inflammation (HP:0004386) | 1.81329438 |
| 74 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.81137584 |
| 75 | Abnormality of the nasal mucosa (HP:0000433) | 1.80701252 |
| 76 | Trismus (HP:0000211) | 1.80471718 |
| 77 | Colitis (HP:0002583) | 1.75542925 |
| 78 | Generalized amyotrophy (HP:0003700) | 1.75449619 |
| 79 | Pathologic fracture (HP:0002756) | 1.75227409 |
| 80 | Amyloidosis (HP:0011034) | 1.75209991 |
| 81 | Gingivitis (HP:0000230) | 1.74592701 |
| 82 | Diminished motivation (HP:0000745) | 1.72825941 |
| 83 | Apathy (HP:0000741) | 1.72809188 |
| 84 | Hypercortisolism (HP:0001578) | 1.72681215 |
| 85 | Asymmetry of the thorax (HP:0001555) | 1.72367163 |
| 86 | Vasculitis (HP:0002633) | 1.70821398 |
| 87 | Nasal polyposis (HP:0100582) | 1.70539556 |
| 88 | Myopathic facies (HP:0002058) | 1.69645216 |
| 89 | Systemic lupus erythematosus (HP:0002725) | 1.69235723 |
| 90 | Abdominal distention (HP:0003270) | 1.69186336 |
| 91 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.68339141 |
| 92 | Growth hormone excess (HP:0000845) | 1.67226709 |
| 93 | Recurrent skin infections (HP:0001581) | 1.66999699 |
| 94 | Malnutrition (HP:0004395) | 1.66881736 |
| 95 | Blue sclerae (HP:0000592) | 1.66465690 |
| 96 | Progressive external ophthalmoplegia (HP:0000590) | 1.65717152 |
| 97 | Cupped ribs (HP:0000887) | 1.65670527 |
| 98 | Bulbar palsy (HP:0001283) | 1.65378603 |
| 99 | Dilatation of the ascending aorta (HP:0005111) | 1.64818502 |
| 100 | Neurofibrillary tangles (HP:0002185) | 1.64727283 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TRIB3 | 4.70951669 |
| 2 | ERN1 | 3.27501005 |
| 3 | PRPF4B | 3.12542792 |
| 4 | NME2 | 3.04420993 |
| 5 | IRAK3 | 2.96491640 |
| 6 | SMG1 | 2.83375278 |
| 7 | SIK1 | 2.70120456 |
| 8 | RIPK4 | 2.25102020 |
| 9 | TAOK2 | 1.96141202 |
| 10 | MAP4K1 | 1.92201516 |
| 11 | ICK | 1.85364199 |
| 12 | TESK1 | 1.81855101 |
| 13 | MAP2K3 | 1.80370147 |
| 14 | EPHA2 | 1.74090513 |
| 15 | MAP3K13 | 1.71874627 |
| 16 | IRAK4 | 1.69768761 |
| 17 | SIK3 | 1.67250839 |
| 18 | MAP3K11 | 1.65335752 |
| 19 | PKN2 | 1.63797612 |
| 20 | TAOK1 | 1.60985138 |
| 21 | TESK2 | 1.58621657 |
| 22 | TBK1 | 1.56394765 |
| 23 | ARAF | 1.55780724 |
| 24 | MAP3K14 | 1.52004638 |
| 25 | CDK12 | 1.50204340 |
| 26 | EEF2K | 1.43312887 |
| 27 | MAP3K3 | 1.41014592 |
| 28 | KSR2 | 1.33037395 |
| 29 | FGFR4 | 1.32986236 |
| 30 | PAK4 | 1.27084889 |
| 31 | EPHB1 | 1.21386648 |
| 32 | TYK2 | 1.15801446 |
| 33 | PRKD2 | 1.15276618 |
| 34 | GRK6 | 1.13999886 |
| 35 | RIPK1 | 1.13566148 |
| 36 | PDPK1 | 1.09739090 |
| 37 | MAP3K1 | 1.08434221 |
| 38 | MAP2K2 | 1.03997091 |
| 39 | PTK6 | 0.96655000 |
| 40 | IRAK2 | 0.96496561 |
| 41 | ZAP70 | 0.96116910 |
| 42 | RPS6KB2 | 0.93640412 |
| 43 | MAPKAPK3 | 0.92814248 |
| 44 | SIK2 | 0.90766888 |
| 45 | SCYL2 | 0.89202631 |
| 46 | MOS | 0.88137744 |
| 47 | TTN | 0.87823372 |
| 48 | MARK2 | 0.84601218 |
| 49 | LRRK2 | 0.83474002 |
| 50 | BRAF | 0.82960174 |
| 51 | CDC42BPA | 0.82796243 |
| 52 | CSK | 0.82099677 |
| 53 | CDK19 | 0.79422756 |
| 54 | PIM2 | 0.78546497 |
| 55 | TNK2 | 0.78314037 |
| 56 | JAK3 | 0.75516657 |
| 57 | PRKD3 | 0.75241148 |
| 58 | IKBKB | 0.74415516 |
| 59 | HIPK2 | 0.73284511 |
| 60 | LMTK2 | 0.72626988 |
| 61 | PDK1 | 0.72132199 |
| 62 | IKBKE | 0.70216667 |
| 63 | ILK | 0.70067487 |
| 64 | BLK | 0.69483548 |
| 65 | FGR | 0.68790774 |
| 66 | RPS6KC1 | 0.68000601 |
| 67 | RPS6KL1 | 0.68000601 |
| 68 | MAP3K10 | 0.64772167 |
| 69 | PDGFRA | 0.63723022 |
| 70 | MAP3K8 | 0.62131472 |
| 71 | RPS6KA2 | 0.58426565 |
| 72 | CSF1R | 0.57501235 |
| 73 | TYRO3 | 0.55414386 |
| 74 | BMX | 0.54195592 |
| 75 | BTK | 0.53604024 |
| 76 | DDR2 | 0.52871533 |
| 77 | RET | 0.51507051 |
| 78 | HCK | 0.49437320 |
| 79 | PTK2 | 0.48962589 |
| 80 | MAP3K9 | 0.48319288 |
| 81 | CAMKK1 | 0.47827297 |
| 82 | MATK | 0.47452320 |
| 83 | PRKG2 | 0.47191010 |
| 84 | MTOR | 0.46022750 |
| 85 | RPS6KA6 | 0.44681915 |
| 86 | MAPK11 | 0.44652462 |
| 87 | MAPKAPK2 | 0.44494583 |
| 88 | CHUK | 0.44207882 |
| 89 | ABL2 | 0.43783194 |
| 90 | LATS2 | 0.42764190 |
| 91 | LIMK1 | 0.42518200 |
| 92 | DYRK1B | 0.40448188 |
| 93 | FES | 0.39481445 |
| 94 | STK38 | 0.37895584 |
| 95 | CDK4 | 0.36250343 |
| 96 | JAK2 | 0.35869237 |
| 97 | CDK7 | 0.35125938 |
| 98 | DAPK3 | 0.34180469 |
| 99 | MAPK4 | 0.33394714 |
| 100 | DMPK | 0.33188270 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 2.88761234 |
| 2 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.42829037 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.17173283 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.13547420 |
| 5 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 2.08361483 |
| 6 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.94314525 |
| 7 | Leishmaniasis_Homo sapiens_hsa05140 | 1.88675851 |
| 8 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.86331423 |
| 9 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.79595481 |
| 10 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.73397357 |
| 11 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.71207504 |
| 12 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.66458756 |
| 13 | Lysosome_Homo sapiens_hsa04142 | 1.62376088 |
| 14 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.54129720 |
| 15 | Sulfur relay system_Homo sapiens_hsa04122 | 1.52954161 |
| 16 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.52869052 |
| 17 | Prion diseases_Homo sapiens_hsa05020 | 1.49650831 |
| 18 | Bladder cancer_Homo sapiens_hsa05219 | 1.49425277 |
| 19 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.44478181 |
| 20 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.40890745 |
| 21 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.39934577 |
| 22 | Pancreatic cancer_Homo sapiens_hsa05212 | 1.39189252 |
| 23 | Tuberculosis_Homo sapiens_hsa05152 | 1.38895466 |
| 24 | Influenza A_Homo sapiens_hsa05164 | 1.37709348 |
| 25 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.36982598 |
| 26 | Hepatitis C_Homo sapiens_hsa05160 | 1.36103654 |
| 27 | Allograft rejection_Homo sapiens_hsa05330 | 1.35630934 |
| 28 | Shigellosis_Homo sapiens_hsa05131 | 1.29991878 |
| 29 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.29571063 |
| 30 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.22230729 |
| 31 | Salmonella infection_Homo sapiens_hsa05132 | 1.21696216 |
| 32 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 1.21532930 |
| 33 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.20928423 |
| 34 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.19137622 |
| 35 | Hepatitis B_Homo sapiens_hsa05161 | 1.18628324 |
| 36 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.18159243 |
| 37 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16280437 |
| 38 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.15544686 |
| 39 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.14496014 |
| 40 | Measles_Homo sapiens_hsa05162 | 1.13608814 |
| 41 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.13232790 |
| 42 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.12948851 |
| 43 | Apoptosis_Homo sapiens_hsa04210 | 1.10283003 |
| 44 | Malaria_Homo sapiens_hsa05144 | 1.09598660 |
| 45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.09330046 |
| 46 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.09278065 |
| 47 | Viral myocarditis_Homo sapiens_hsa05416 | 1.08979263 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 1.06878027 |
| 49 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.04325749 |
| 50 | Endocytosis_Homo sapiens_hsa04144 | 1.01954687 |
| 51 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.00053768 |
| 52 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.99669827 |
| 53 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.99205619 |
| 54 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.98510055 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.98163979 |
| 56 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.95524299 |
| 57 | Endometrial cancer_Homo sapiens_hsa05213 | 0.95325569 |
| 58 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.92909973 |
| 59 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.92784344 |
| 60 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.91676567 |
| 61 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.90471715 |
| 62 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.88142602 |
| 63 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.86460632 |
| 64 | Amoebiasis_Homo sapiens_hsa05146 | 0.85651842 |
| 65 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.85481954 |
| 66 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.85093170 |
| 67 | Pertussis_Homo sapiens_hsa05133 | 0.83608016 |
| 68 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.83287061 |
| 69 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.82949257 |
| 70 | HTLV-I infection_Homo sapiens_hsa05166 | 0.82760238 |
| 71 | Thyroid cancer_Homo sapiens_hsa05216 | 0.81706568 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.80440929 |
| 73 | Phagosome_Homo sapiens_hsa04145 | 0.80092377 |
| 74 | Ribosome_Homo sapiens_hsa03010 | 0.79787496 |
| 75 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.79246172 |
| 76 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.78817443 |
| 77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.78334389 |
| 78 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.76771753 |
| 79 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.76623993 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.74703776 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.72533471 |
| 82 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.70892779 |
| 83 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.69057924 |
| 84 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.68513343 |
| 85 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.68438469 |
| 86 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.64679437 |
| 87 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.64144867 |
| 88 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.63917088 |
| 89 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.63872126 |
| 90 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.63869378 |
| 91 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.62988705 |
| 92 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.60299635 |
| 93 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.59424511 |
| 94 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.59056445 |
| 95 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.58790256 |
| 96 | Prostate cancer_Homo sapiens_hsa05215 | 0.57955469 |
| 97 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.56736194 |
| 98 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.56175394 |
| 99 | Insulin resistance_Homo sapiens_hsa04931 | 0.55881782 |
| 100 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.54283193 |

